ASCIL BIOPHARM
ASCIL Biopharm is a drug-delivery company developing proprietary miniaturized injectable and locally acting therapeutics to enhance the safety, effectiveness, and convenience of administration of drugs for chronic high burden diseases. The company's mission is to create pharmaceutical products and therapeutic treatments of improved efficacy, comfort, and compliance through its new patented DDS technology platforms.
ASCIL BIOPHARM
Industry:
Health Care
Website Url:
http://www.ascil-biopharm.com
Total Employee:
11+
Status:
Active
Contact:
+34934137922
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
BIND Therapeutics
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2016-10-25 | Iproteos | ASCIL Biopharm investment in Venture Round - Iproteos | 1.5 M EUR |
Official Site Inspections
http://www.ascil-biopharm.com
- Host name: vxhcf-03.srv.cat
- IP address: 185.66.41.31
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
